Dear All, Apologies as I have not gotten this out sooner. I am currently unable to have easy access to email right now. However, I plan on being there for our upcoming meeting. For this week's meeting, we will be continuing our last discussion of Closed Generics. Last week we went over the con arguments of the public comment as well as exploring what the potential harms are. I use the word potential because the current RA does not allow for Closed Generics, as such we are unable to determine if any of these are actual harm. If someone does have evidence of actual harm, then please bring it up for discussion. However, we will be seeking proposals and ideas for how we can compromise for a way to allow Closed Generics. If you have any thoughts, we would very much appreciate them. Kind regards, Michael Flemming